The relationship between depression, anxiety and heart disease - A psychosomatic challenge;Der zusammenhang von depression, angst und herzerkrankung - Eine psychosomatische herausforderung

Psychiatria Danubina

Volumn 23, Issue 4, 2011, Pages 412-424

  Kapfhammer, Hans Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Anxiety; Depression; Epidemiology; Heart disease; Neurobiologcal; Posttraumatic stress disorder; Psychological; Treatment

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ALEXITHYMIA; ANGER; ANHEDONIA; ANXIETY DISORDER; CARDIOTOXICITY; COGNITIVE THERAPY; COMORBIDITY; CONFERENCE PAPER; DEPRESSION; DISEASE ASSOCIATION; EXHAUSTION; HEART DISEASE; HEART INFARCTION; HOPELESSNESS; HOSTILITY; HUMAN; ISCHEMIC HEART DISEASE; MENTAL STRESS; MORTALITY; NEUROBIOLOGY; PERSONALITY; POSTTRAUMATIC STRESS DISORDER; PROGNOSIS; PSYCHOSOMATICS;

ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COMBINED MODALITY THERAPY; COMORBIDITY; COOPERATIVE BEHAVIOR; DEPRESSIVE DISORDER; HEART DISEASES; HUMANS; INTERDISCIPLINARY COMMUNICATION; MYOCARDIAL INFARCTION; PSYCHOPHYSIOLOGIC DISORDERS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERRAL AND CONSULTATION; RISK FACTORS;

EID: 82155191312     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (125)

1. Abbas CC, Schmid JP, Guler E, et al. Trajectory of posttraumatic stress disorder caused by myocardial infarction: a two-year follow-up study. Int J Psychiatry Med 2009; 39:359-376.
2. Albus C. Psychological and social factors in coronary heart disease. Ann Med 2010; 42:487-494.
3. Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL. Association between anxiety and C-reactive protein levels in stable coronary heart disease patients. Psychosomatics 50:347-353.
4. Bass C. Cardiorespiratory disorders. In: Lloyd GG, Guthrie E (eds) Handbook of liaison psychiatry. Cambridge University Press, Cambridge 2007; 365-389.
5. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289:3106-3116.
6. Bozzini S, Gambelli P, Boiocchi C, et al. Coronary artery disease and depression: Possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms. Int J Mol Med 2009; 24:813-818.
7. Brown ADH, Barton DA, Lambert GW. Cardiovascular abnormalities in patients with major depressive disorder. Autonomic mechanisms and implications for treatment. CNS Drugs 2009; 23: 583-602.
8. Bucceletti E, Gilardi E, Scaini E, et al. Heart rate variability and myocardial infarction: systematic literature review and manalysis. Eur Rev Med Pharmacol Sci 2009; 299-307.
9. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. J Psychosom Res 2002; 53: 897-902. (Pubitemid 35282619)
10. Carney RM, Freedland KE, Rubin EH, et al. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: A randomized controlled trial. JAMA 2009; 302: 1651-1657.
11. Carney RM, Freedland KE. Depression and heart rate variability in patients with coronary heart disease. Cleve Clin J Med 2009c; 76 (suppl 2): S13-S17.
12. Carney RM, Freedland KE. Psychotherapies for depression in people with heart disease. In: Glassman A, Maj M, Sartorius N (eds) Depression and heart disease. Wiley-Blackwell, Oxford 2011; 145-168
13. Carney RM, Freedland KE. Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 2009b; 166: 410-417.
14. Carney RM, Freedland KE. Treatment-resistant depression and sudden cardiac death. J Am Coll Cardiol 2009a; 54: 958-959.
15. Carney RM, Freedland KE, Steinmeyer B, et al. Depression and five year survival following acute myocardial infarction: A prospective study. J Affect Disord 2008; 109: 133-138.
16. Chen H. Possible role of platelet GluR1 receptors in comorbid depression and cardiovascular disease. Cardiovasc Psychiatry Neurol 2009; 111: 424-728.
17. Chen YH, Tsai SY, Lee HC, Lin HC. Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study. Psychosom Med 2009; 71: 798-804.
18. Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol 2009; 53: 936-946.
19. Cohen BE, Marmar CR, Neylan TC. Posttraumatic stress disorder and health-related quality of life in patients with coronary heart disease: Findings from the heart and soul study. Arch Gen Psychiatry 2009; 66: 1214-1220.
20. Cotter G, Milo-Cotter O, Rubinstein D, Shemesh E. Posttraumatic stress disorder: A missed link between psychiatric and cardiovascular morbidity? CNS Spectr 2006; 11:129-136.
21. Cowan MJ, Freedland KE, Burg MM, et al. Predictors of treatment response for depression and inadequate social support - The ENRICHD randomized controlled trial. Psychother Psychosom 2008; 77: 27-37. (Pubitemid 350261945)
22. Dao TK, Youssef NA, Gopaldas RR, et al. Autonomic cardiovascular dysregulation as a potential mechanism underlying depression and coronary artery bypass grafting surgery outcomes. J Cardiothorac Surg 2010; 5: 36.
23. Davidson KW. Emotional predictors and behavioral triggers of acute coronary syndrome. Cleve Clin J Med 2008; 75 (suppl 2): S15-S19.
24. de Jonge P, Kempen GIJM, Sanderman R, et al. Depressive symptoms in elderly patients after a somatic illness event. Psychosomatics 2006; 47: 33-42.
25. de Jonge P, Mangano D, Whooley MA. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Psychosom Med 2007; 69:735-739. (Pubitemid 350287480)
26. de Jonge P, Rosmalen JG, Kema IP, et al. Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: A critical review of the literature. Neurosci Biobehav Rev 2010; 35:84-90.
27. Denollet J, de Jonge P, Kuyper A, et al. Depression and Type D personality represent different forms of distress in the Myocardial INfarction and Depression - Intervention Trial (MND-IT). Psychol Med 2009; 39:749-756.
28. Denollet J, Pedersen SS. Anger, depression, and anxiety in cardiac patients: the complexity of individual differences in psychological risk. Am Coll Cardiol 2009; 53: 947-949.
29. Dickens CM, McGowan L, Percival C et al. Lack of a close confidant, but not depression, predicts further cardiac events after myocardial infarction. Heart 2004;90: 518-522 (Pubitemid 38530168)
30. Dunn SL, Corser W, Stommel M, Holmes-Rovner M. Hopelessness and depression in the early recovery period after hospitalization for acute coronary syndrome. J Cardiopulm Rehabil 2006; 26:152-159 (Pubitemid 44491097)
31. Esler M. Heart and mind: Psychogenic cardiovascular disease. J Hypertension 2009; 27:692-695.
32. Evangelista O, McLaughlin MA. Review of cardiovascular risk factors in women. Gend Med 2009; 6: 17-36.
33. Figueredo VM. The time has come for physicians to take notice: The impact of psychosocial stressors on the heart. Am J Med 2009; 122:704-712.
34. Frasure-Smith N, Lespérance F. Depression and cardiac risk: Present status and future directions. Heart 2010; 96:173-176.
35. Freedland KE, Skala JA, Carney RM, et al.Treatment of depression after coronary artery bypass surgery. A randomized controlled trial. Arch Gen Psychiatry 2009; 66: 387-396.
36. Friedman M, Rosenman RH. Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. JAMA 1959; 169: 1286-1296.
37. Gander ML, von Känel R. Myocardial infarction and posttraumatic stress disorder: Frequency, outcome, and atherosclerotic mechanisms. Eur J Cardiovasc Prev Rehabil 2006; 13: 165-172.
38. Glassman A. Depression and cardiovascular disease. Pharmacopsychiatry 2008; 41: 221-225.
39. Glassman AH, Bigger JT Jr, Gaffney M. Psychiatric characteristics associated with long term mortality among 361 patients having an acute coronary syndrome and major depression: Seven-year follow-up of SADHART participants. Arch Gen Psychiatry 2009; 66: 1022-1029.
40. Glassman AH, O'Connor CM, Califf RM et al. for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701-709. (Pubitemid 34848222)
41. Glazer KM, Emery CF, Frid DJ, Banyasz RE. Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. J Cardiopulm Rehabil 2002; 22: 40-46.
42. Goldston K, Baillie AJ. Depression and coronary heart disease: A review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin Psychol Rev 2008; 28: 288-306.
43. Grippo AJ, Johnson AK. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009; 12: 1-21.
44. Hamer M, Malan L. Psychophysiological risk markers of cardiovascular disease. Neurosci Biobehav Rev 2010; 35: 76-83.
45. Hari R. Begre S, Schmid JP, et al. Change over time in posttraumatic stress caused by myocardial infarction and predicting variables. J Psychosom Res 2010; 69: 143-150.
46. Hausteiner C, Klupsch D, Emeny R, et al. Clustering of negative affectivity and social inhibition in the community: Prevalence of type D personality as a cardiovascular risk marker. Psychosom Med 2010; 72: 163-171.
47. Hayes SN. Broken-hearted women: The complex relationship between depression and cardiovascular disease. Womens Health 2009; 5: 709-725.
48. Honig A, Kuyper AM, Schene AH, et al. Treatment of postmyocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med 2007; 69: 606-613. (Pubitemid 47463817)
49. Huffman JC, Celano CM, Januzzi JL. The relationship between depression, anxietym and cardiovascular outcomes in patients with acute coronary syndromes. Neuropsychiatr Dis Treat 2010; 6: 123-136.
50. Janeway D. An integrated approach to the diagnosis and treatment of anxiety within the practice of cardiology. Cardiol Rev 2009; 17: 36-43.
51. Janszky I, Ahnve S, Lundberg I, Hemmingsson T. Early onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol 2010; 56: 31-37.
52. Jiang W, Xiong GL. Epidemiology of the comorbidity between depression and heart disease. In: Glassman A, Maj M, Sartorius N (eds) Depression and heart disease. Wiley-Blackwell, Oxford 2011; 1-37.
53. Kapfhammer HP. Konsiliar- und Liaisonpsychiatrie. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie, Psychosomatik und Psychotherapie. 4. Aufl. Springer Verlag, Berlin Heidelberg New York 2011 c; 1297-1318.
54. Kapfhammer HP. Psychische Störungen bei somatischen Krankheiten. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie, Psychosomatik und Psychotherapie. 4. Aufl. Springer Verlag, Berlin Heidelberg New York, 2011 a; 1319-1405.
55. Kapfhammer HP. Psychosomatische Medizin - Einleitung und Übersicht. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie, Psychosomatik und Psychotherapie. 4. Aufl. Springer Verlag, Berlin Heidelberg New York 2011 b; 1273-1296.
56. Katerndahl DA. The association between panic disorder and coronary artery disease among primary care patients presenting with chest pain: An updated literature review. Prim Care Companion J Clin Psychiatry 2008; 10:276-285.
57. Kendler KS, Gardner CO, Fiske A, Gatz M. Major depression and coronary artery disease in the Swedish Twin Registry. Arch Gen Psychiatry 2009; 66:857-863.
58. Kent LK, Shapiro PA. Depression and related psychological factors in heart disease. Harv Rev Psychiatry 2009; 17:377-388.
59. Khan FM, Kulaksizoglu B, Cilingiroglu M. Depression and coronary heart disease. Curr Atheroscler Rep 2010; 12: 105-109.
60. Kitzler va E, Anders M. The role of some new factors in the pathophysiology of depression and cardiovascular disease: Overview of recent research. Neuroendocrinal Lett 2007; 28: 832-840.
61. Korkeila J, Vahtera J, Korkeila K, et al. Childhood adversities as predictors of incident coronary heart disease and cerebrovascular disease. Heart 2010; 96: 298-303.
62. Krantz DS, Whittaker KS, Francis JL, et al. Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: Outcome from the Women' s Ischemia Syndrome Evaluation (WISE) study. Heart 2009; 95: 1901-1906.
63. Kubzansky LD, Koenen KC. Is posttraumatic stress disorder related to development of heart disase? An update. Clece Clin J Med 2009; 76 (suppl 2): S60-S65.
64. Kuyper AMG, Honig A. Treatment of post-myocardial infarction depressive disorder. Expert Rev Neurother 2008; 8: 1115-1123. (Pubitemid 351962078)
65. Ladwig KH, Emery RT, Häfner S, Lacruz ME. Depression. Ein nach wie vor unterschätztes Risiko für die Entwicklung und Progression der koronaraen Herzerkrankung. Bundesgesundheitsbl 2011; 54: 59-65.
66. Lane DA, Chong AY, Lip GYH. Psychological interventions for depression in heart failure (Review). Cochrane Database Syst Rev 2009; 1: CD003329.
67. Leroy M, Loas G, Perez-Diaz F. Anhedonia as predictor of clinical events after acute coronary syndromes: A 3-year prospective study. Compr Psychiatry 2010; 51: 8-14.
68. Lespérance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007; 297: 367-379. (Pubitemid 46155798)
69. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 108: 1049-1053. (Pubitemid 34212612)
70. Lett HS, Sherwood A, Watkins L, Blumenthal JA. Depression and prognosis in cardiac patients. In: Steptoe A (ed) Depression and physical illness. Cambridge University Press, Cambridge 2006; 87-108.
71. Levenson JL, Dwight M. Cardiology. In: Stoudemire A, Fogel BS, Greenberg DB (eds) Psychiatric care of the medical patient, 2nd edn. Oxford University Press, Oxford, New York 2000; 717-731.
72. Linke SE, Rutledge T, Johnson D, et al. Depressive symptom dimensions and cardiovascular prognosis among women with suspected mocardial ischemia. Arch Gen Psychiatry 2009; 66: 499-507.
73. Low CA, Thurston RC, Matthews KA. Psychosocial factors in the development of heart disease in women: Current research and future directions. Psychosom Med 2010; 72: 842-854.
74. Martens EJ, de Jonge P, Na B, Cohen BE, Lett H, Whooley MA. Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease: The Heart and Soul Study. Arch Gen Psychiatry 2010; 67: 750-758.
75. Martens EJ, Hoen PW, Mittelhaeuser M, et al. Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med 2010; 40: 807-814.
76. Meyer T, Buss U, Herrmann-Lingen C. Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality. Psychosom Med 2010; 72: 9-15.
77. Mols F, Denollet J. Type D personality among noncardiovascular patient populations: A systematic review. Gen Hosp Psychiatry 2010; 32: 66-72.
78. Mols F, Martens EJ, Denollet J. Type D personality and depressive symptoms are independent predictors of impaired health status following acute myocardial infarction. Heart 2010; 96: 30-35.
79. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 1998; 55: 580-592.
80. Narayan SM, Stein MB. Do depression or antidepressants increase cardiovascular mortality? The absence of proof might be more important than the proof of absence. J Am Coll Cardiol 2009; 53: 950-958.
81. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774. (Pubitemid 44871461)
82. Otte C, McCaffery J, Ali S, Whooley MA. Association of serotonin transporter polymorphism (5-HTTLPR) with depression. Perceived stress, and norepinephrine in patients with coronary disease: The heart and Soul Study. Am J Psychiatry 2007; 164: 1379-1384. (Pubitemid 47461138)
83. Pedersen SS, Denollet J, Daemen J, et al. Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. J Psychosom Res 2007; 62: 455-461. (Pubitemid 46441263)
84. Penninx BW, Beekman AT, Honig A et al. Depression and cardiac mortality: Results from a community-based longitudinal study. Arch Gen Psychiatry 2001; 58:221-227. (Pubitemid 32209674)
85. Pizzi C, Rutjes AWS, Costa GM, et al. Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. Am J Cardiol 2011; 107:972-979.
86. Rees K, Bennett P, West R et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2004; CD002902.
87. Roest AM, Martens EJ, Denollet J, de Jonge P. Prognostic association of anxiety postmyocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 2010; 72:563-569.
88. Roose SP, Dalack GW, Glassman AH et al. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 1991; 148:512-516.
89. Roose SP, Laghrissi-Thode F, Kennedy JS et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998; 279: 287-291. (Pubitemid 28071019)
90. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003; 54: 227-240. (Pubitemid 37267853)
91. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 2002; 23: 51-61. (Pubitemid 34687133)
92. Rutledge T, Linke SE, Krantz DS, et al. Comorbid depression and anxiety symptoms as predictors of cardiovascular events: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Psychosom Med 2009; 71: 958-964.
93. Seymour J, Benning TB. Depression, cardiac mortality and all-cause mortality. Adv Psychiatr Treatment 2009; 15: 107-113.
94. nd ed. American Psychiatric Publishing, London, Washington 2011; 407-440.
95. Skala JA, Freedland KE, Carney RM. Coronary heart disease and depression: A review of recent mechanistic research. Can J Psychiatry 2006; 51: 738-745. (Pubitemid 44656504)
96. Skodova Z, Nagyova I, van Dijk JP, et al. Socioeconomic differences in psychosocial factors contributing to coronary heart disease: a review. J Clin Psychol Med Settings 2008; 15: 204-213.
97. Smaller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med 2009; 169: 2128-2139.
98. Smoller JW, Pollack MH, Wassertheil-Smoller S, et al. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry 2007; 64: 1153-1160. (Pubitemid 47529339)
99. Spitzer C, Barnow S, Völzke H, et al. Trauma, posttraumatic stress disorder, and physical illness: Findings from the general population. Psychosom Med 2009; 71: 1012-1017.
100. Srebruany VL, Suckow RF, Cooper TB. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am J Psychiatry 2005; 162: 1165-1170. (Pubitemid 40770700)
101. Steptoe A, Brydon L. Emotional triggering of cardiac eevents. Neurosci Biobehav Rev 2009; 33: 63-70.
102. Steptoe A. Depression and the development of coronary heart disease. In: Steptoe A (ed) Depression and physical illness. Cambridge University Press, Cambridge 2006; 53-86.
103. Strik JJ, Honig A, Lousberg R et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: Findings from a double-blind, placebo-controlled trial. Psychosom Med 2000; 62: 783-789. (Pubitemid 32009084)
104. Sullivan M, LaCroix A, Russo J et al. Depression in coronary heart disease. What is the appropriate diagnostic threshold? Psychosomatics 1999; 40: 286-292. (Pubitemid 29315947)
105. Summers KM, Martin KE, Watson K. Impact and clinical management of depression in patients with coronary artery disease. Pharmacotherapy 2010; 30:304-322.
106. Taylor CB, Youngblood ME, Catellier D et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005; 62: 792-798. (Pubitemid 41002762)
107. Thayer JF, Lane RD. Claude Bernard and the heart-brain connection: Further elaboration of a model of visceral integration. Neurosci Biobehav Rev 2009; 33: 81-88.
108. Thayer JF, Lane RD. The role of vagal function in the risk for cardiovascular disaes and mortality. Biol Psychology 2007; 74: 224-242. (Pubitemid 46001789)
109. Tiihonen J, Lönnqvist J, Wahlbeck K, et al. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 2006; 63: 1358-1367. (Pubitemid 44878519)
110. Tolmunen T, Lehto SM, Heliste M, et al. Alexithymia is associated with increased cardiovascular mortality in middle-aged Finnish men. Psychosom Med 2010; 72: 187-191.
111. Tully PJ, Baker RA, Knight JL. Anxiety and depression as risk factors for mortality after coronary artery bypass surgery. J Psychosom Res 2008; 64: 285-290. (Pubitemid 351248872)
112. Tully PJ, Baker RA, Turnbull DA, et al. Negative emotions and quality of life six months after cardiac surgery: the dominant role of depression not anxiety symptoms. J Behav Med 2009; 32: 510-522.
113. van der Kooy K, van Hout H, Marwijk H, et al. Depression and the risk for cardiovascular diseases: Systematic review and meta-analysis. Int J Geriatr Psychiatry 2007; 22: 613-626. (Pubitemid 47180373)
114. van Zyl LT, Lespérance F, Frasure-Smith N, et al. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study. J Thromb Thrombolysis 2009; 27: 48-56.
115. Vieweg WV, Hasnain M, Lesnefsky EJ, et al. Assessing the presence and severity of depression in subjects with comorbid coronary heart disease. Am J Med 2010; 123: 683-690.
116. Vogelzangs N, Seldenrijk A, Beekman AT, et al. Cardiovascular disease in person with depressive and anxiety disorders. J Affect Disord 2010; 125: 241-248.
117. Von Känel R, Begre S, Abbas CC, et al. Inflammatory biomarkers in patients with posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms. Neuroimmunomodulation 2010 b; 17: 39-46.
118. Von Känel R, Schmid JP, Abbas CC, et al. Stress hormones in patients with posttraumatic stress disorder caused by myocardial infarction and role of comorbid depression. J Affect Disord 2010 a; 121: 73-79.
119. Wang L, van Belle G, Kukull WB, Larson EB. Predictors of functional change: A longitudinal study of nondemented people aged 65 and older. J Am Geriatr Soc 2002; 50:1525-1534. (Pubitemid 35024645)
120. Watkins LL, Blumenthal JA, Babyak MA, et al. Prospective association between phobic anxiety and cardiac mortality in individuals with coronary heart disease. Psychosom Med 2010; 72:664-671.
121. Whang W, Kubzansky LD, Kawachi I, et al. Depression and risk of sudden cardiac death and coronary heart disease in women. Results from the Nurses' Health Study. J Am Coll Cardiol 2009; 53:950-958.
122. Whitehead D, Perkins-Porras L, Strike PC, Steptoe A. Post-traumatic stress disorder in cardiac patients: Predicting vulnerability from emotional responses during admission for acute coronary syndromes. Heart 2006; 92:1225-1229. (Pubitemid 44298865)
123. Wiedemar L, Schmid JP, Müller J et al. Prevalence and predictors of posttraumatic stress disorders in patients with acute myocardial infarction. Heart Lung 2008; 37:113-121. (Pubitemid 351417654)
124. Williams JE, Mosley TH Jr, Kop WJ, et al. Vital exhaustion as a risk factor for adverse cardiac events (from the Atherosclerosis Risk In Communities (ARIC) study). Am J Cardiol 2010; 105:1661-1665.
125. Zafar MU, Paz-Yepes M, Shimbo D, et al. Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J 2010; 31:1573-1582.